Not currently recruiting at UCSF
Safety and Efficacy Trial of AAV Gene Therapy in Patients With CNGB3 Achromatopsia
a study on Achromatopsia
Achromatopsia Color Vision Defects rAAV2tYF-PR1.7-hCNGB3
Lead Scientist at UCSF
- Jacque Duncan
Retinitis pigmentosa (RP) affects about 1 in 3,500 people worldwide. Age-related macular degeneration (AMD) affects as many as 1 in 4 people by the age of 75 and is the leading cause of blindness in people over age 50 in the United States. Both RP and AMD have a hereditary basis, and currently, there is no cure for either of these types of hereditary retinal degeneration.